2KR-23226-78330
4 vaccinations
23 coded responses
54 check-ins
21 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 151 / PA
- Registered
- 2021-04-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-23
Registered in v-safe
-
2021-04-23
Dose 1 — Pfizer-BioNTech
-
2021-04-23
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
-
2021-04-24
Survey response — days 1–6 daily, dose 1MedDRA: Decreased appetite — Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Lack of appetiteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-25
- 2021-04-26
- 2021-04-27
-
2021-04-28
Survey response — days 1–6 daily, dose 1MedDRA: Menstruation irregular — Feeling: GoodFree text: Breakthrough bleeding on birth control, early periodMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-29
Survey response — days 1–6 daily, dose 1MedDRA: Intermenstrual bleeding, Menstrual disorder — Feeling: GoodFree text: Breakthrough bleeding/early period on birth control pillMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-30
Survey response — day 7, dose 1MedDRA: Dysmenorrhoea, Heavy menstrual bleeding, Polymenorrhoea — Feeling: Good · Abdominal painFree text: Early and heavier than normal period flowand crampingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-07
-
2021-05-13
Dose 2 — Pfizer-BioNTech
-
2021-05-13
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-14
Survey response — days 1–6 daily, dose 2MedDRA: Gastrooesophageal reflux disease — Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesFree text: RefluxMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-15
Survey response — days 1–6 daily, dose 2MedDRA: Unevaluable event — Feeling: Good · Site: Pain, Swelling · Fever · Fatigue or tiredness, Diarrhea · Be unable to workFree text: Armpit lymph nodeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Swelling · Muscle or body aches, DiarrheaAdult check-in
- 2021-05-17
-
2021-05-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling, Itching · Nausea, Diarrhea, Rash, not including the immediate area around the injection site · Be unable to workAdult check-in
-
2021-05-19
Survey response — days 1–6 daily, dose 2MedDRA: Menstruation irregular — Feeling: GoodFree text: Breakthrough period bleedingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-20
-
2021-05-27
Survey response — day 14, dose 2MedDRA: Menstrual disorder — Feeling: GoodFree text: Started period early even tho on the pill. This also happened with first doseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-03
Survey response — day 21, dose 2MedDRA: Amenorrhoea, Vaginal haemorrhage — Feeling: FairFree text: Spotting and breakthrough bleeding on pill then no period during normal period timeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-10
- 2021-06-17
- 2021-06-24
-
2021-08-12
Survey response — 3 months, dose 2MedDRA: Vaginal haemorrhage — Feeling: GoodFree text: Spotting on the birth control pillMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-11-11
-
2021-12-02
Dose 3 — Pfizer-BioNTech
-
2021-12-02
Survey response — day 0, dose 3MedDRA: Pain in extremity — Feeling: Poor · Site: Pain · Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Arm pain down entire armMedDRA releases: 2024-11 · check-in free text available
-
2021-12-03
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-12-04
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-12-05
Survey response — days 1–6 daily, dose 3MedDRA: Skin warm — Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Nausea, Diarrhea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Arm is hot to touchMedDRA releases: 2024-11 · check-in free text available
-
2021-12-06
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling, Itching · DiarrheaAdult check-in
-
2021-12-07
Survey response — days 1–6 daily, dose 3MedDRA: Gastrooesophageal reflux disease — Feeling: Good · Site: SwellingFree text: Acid refluxMedDRA releases: 2024-11 · check-in free text available
-
2021-12-08
Survey response — days 1–6 daily, dose 3MedDRA: Gastrooesophageal reflux disease — Feeling: Good · Site: Redness, Itching · Nausea, DiarrheaFree text: Acid refluxMedDRA releases: 2024-11 · check-in free text available
- 2021-12-09
- 2021-12-16
- 2021-12-23
- 2021-12-30
-
2022-01-06
Survey response — day 35, dose 3MedDRA: Intermenstrual bleeding — Feeling: GoodFree text: Spotting between periodsMedDRA releases: 2024-11 · check-in free text available
- 2022-01-13
- 2022-03-03
- 2022-06-02
-
2022-11-11
Dose 4 — Pfizer-BioNTech
-
2022-11-11
Health check-in — day 0, dose 4Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-11-12
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-11-13
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Itching · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-11-14
Survey response — days 1–6 daily, dose 4MedDRA: Heavy menstrual bleeding, Menstruation irregular — Feeling: Good · Site: Pain, ItchingFree text: Heavier and easier periodMedDRA releases: 2024-11 · check-in free text available
-
2022-11-15
Survey response — days 1–6 daily, dose 4MedDRA: Dysmenorrhoea, Heavy menstrual bleeding — Feeling: Fair · Site: Pain, Redness, Itching · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Heavy period and crampsMedDRA releases: 2024-11 · check-in free text available
-
2022-11-16
Survey response — days 1–6 daily, dose 4MedDRA: Heavy menstrual bleeding — Feeling: GoodFree text: Heavy periodMedDRA releases: 2024-11 · check-in free text available
-
2022-11-17
Survey response — days 1–6 daily, dose 4MedDRA: Heavy menstrual bleeding — Feeling: Good · Site: ItchingFree text: Heavy periodMedDRA releases: 2024-11 · check-in free text available
-
2022-11-18
Survey response — day 7, dose 4MedDRA: Heavy menstrual bleeding — Feeling: GoodFree text: Longer than usual periodMedDRA releases: 2024-11 · check-in free text available
- 2022-11-25
- 2022-12-02
- 2022-12-09
- 2022-12-16
-
2022-12-23
Survey response — day 42, dose 4MedDRA: Heavy menstrual bleeding — Feeling: GoodFree text: Heavier and longer periodsMedDRA releases: 2024-11 · check-in free text available
-
2023-02-10
Survey response — 3 months, dose 4MedDRA: Heavy menstrual bleeding, Intermenstrual bleeding — Feeling: GoodMedDRA releases: 2024-11
-
2023-05-12
Survey response — 6 months, dose 4MedDRA: Heavy menstrual bleeding — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-23 | Pfizer-BioNTech | |
| 2 | 2021-05-13 | Pfizer-BioNTech | |
| 3 | 2021-12-02 | Pfizer-BioNTech | No |
| 4 | 2022-11-11 | Pfizer-BioNTech | No |
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Lack of appetite
Release 8 — days 1–6 daily, dose 1
Systemic reaction (other): Breakthrough bleeding on birth control, early period
Systemic reaction (other): Breakthrough bleeding/early period on birth control pill
Release 8 — day 7, dose 1
Systemic reaction (other): Early and heavier than normal period flowand cramping
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Reflux
Systemic reaction (other): Armpit lymph node
Systemic reaction (other): Breakthrough period bleeding
Release 8 — day 14, dose 2
Symptoms: Started period early even tho on the pill. This also happened with first dose
Release 8 — day 21, dose 2
Symptoms: Spotting and breakthrough bleeding on pill then no period during normal period time
Release 9 — 3 months, dose 2
Symptoms: Spotting on the birth control pill
Release 10 — day 0, dose 3
Systemic reaction (other): Arm pain down entire arm
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Arm is hot to touch
Systemic reaction (other): Acid reflux
Systemic reaction (other): Acid reflux
Release 10 — day 35, dose 3
Symptoms: Spotting between periods
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Heavier and easier period
Systemic reaction (other): Heavy period and cramps
Systemic reaction (other): Heavy period
Systemic reaction (other): Heavy period
Release 12 — day 7, dose 4
Systemic reaction (other): Longer than usual period
Release 12 — day 42, dose 4
Symptoms: Heavier and longer periods
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Amenorrhoea | ✓ | ✓ | ✓ |
| SD | Heavy menstrual bleeding | · | · | ✓ |
| SD | Intermenstrual bleeding | · | · | ✓ |
| SD | Menstrual disorder | ✓ | ✓ | ✓ |
| SD | Vaginal haemorrhage | ✓ | ✓ | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
| SRO | Dysmenorrhoea | ✓ | ✓ | ✓ |
| SRO | Gastrooesophageal reflux disease | ✓ | ✓ | ✓ |
| SRO | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SRO | Intermenstrual bleeding | ✓ | ✓ | ✓ |
| SRO | Menstrual disorder | ✓ | ✓ | ✓ |
| SRO | Menstruation irregular | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | · | · | ✓ |
| SRO | Polymenorrhoea | ✓ | ✓ | ✓ |
| SRO | Skin warm | · | · | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release